Cargando…

FCGR3A: A new biomarker with potential prognostic value for prostate cancer

To screen target gene cluster by bioinformatics analysis and verify them by in vitro experiment and clinicopathological correlation analysis. We try to find a new biomarker with prognostic value for prostate cancer (PCa). 42 candidate marker genes were constructed by protein protein interaction (PPI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zha, Zeyu, Hong, Yuan, Tang, ZhenFeng, Du, Qiuling, Wang, Yan, Yang, Shengbang, Wu, Yongding, Tan, Huijing, Jiang, Funneng, Zhong, Weide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730230/ https://www.ncbi.nlm.nih.gov/pubmed/36505767 http://dx.doi.org/10.3389/fonc.2022.1014888

Ejemplares similares

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis
por: Morgan, Ann W, et al.
Publicado: (2006)

Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment
por: Sun, Wenguo, et al.
Publicado: (2020)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome
por: Mackie, S, et al.
Publicado: (2005)

FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission
por: Milligan, Caitlin, et al.
Publicado: (2015)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

The Prognostic Value of Plasma Cell-Free DNA Concentration in the Prostate Cancer: A Systematic Review and Meta-Analysis
por: Liu, Hongtao, et al.
Publicado: (2021)

Probe Signal Values in mRNA Arrays Imply an Excessive Involvement of Neutrophil FCGR1 in Tuberculosis
por: Wu, Kang, et al.
Publicado: (2020)

Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer
por: Chen, Hui, et al.
Publicado: (2022)

Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer
por: Sun, Guangyu, et al.
Publicado: (2022)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

CNVrd, a Read-Depth Algorithm for Assigning Copy-Number at the FCGR Locus: Population-Specific Tagging of Copy Number Variation at FCGR3B
por: Nguyen, Hoang tan, et al.
Publicado: (2013)

Association of FCGR2A/FCGR3A variant rs2099684 with Takayasu arteritis in the Han Chinese population
por: Chen, Si, et al.
Publicado: (2016)

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
por: Tan, Qiaorui, et al.
Publicado: (2022)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer
por: Ying, Hou-Qun, et al.
Publicado: (2015)

FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant
por: Paul, Pascale, et al.
Publicado: (2019)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
por: Yang, Guo, et al.
Publicado: (2023)

Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity
por: Li, Lilin, et al.
Publicado: (2022)

FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis
por: Sun, Zhimin, et al.
Publicado: (2023)

Association of FCGR3A and FCGR3B Copy Number Variations With Systemic Lupus Erythematosus and Rheumatoid Arthritis in Taiwanese Patients
por: Chen, Ji-Yih, et al.
Publicado: (2014)

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis
por: Márquez Pete, Noelia, et al.
Publicado: (2021)

Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
por: Tan, Ruoyue, et al.
Publicado: (2021)

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer
por: Wang, Zijun, et al.
Publicado: (2020)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
por: Wang, Zhenpeng, et al.
Publicado: (2019)

Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC)
por: Chen, Zhao, et al.
Publicado: (2020)

The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and Progress
por: Samami, Elham, et al.
Publicado: (2022)

Prognostic and diagnostic value of circRNA expression in prostate cancer: A systematic review and meta-analysis
por: Xie, Jingling, et al.
Publicado: (2022)

FCGR2C: An emerging immune gene for predicting sepsis outcome
por: Liu, Si, et al.
Publicado: (2022)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy
por: Feng, Hanxin, et al.
Publicado: (2022)

Incremental prognostic value of ADC histogram analysis in patients with high-risk prostate cancer receiving adjuvant hormonal therapy after radical prostatectomy
por: He, Kangwen, et al.
Publicado: (2023)

Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis
por: Typiak, Marlena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_agk4mfb8rdche899kikikb869l